NPI: 1265615934 · MESA, AZ 85209 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 12/17/2007
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE&CERTIFICATION) |
| NPI Enumeration Date | 12/17/2007 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,019 | $484K |
| 2019 | 13,518 | $480K |
| 2020 | 9,142 | $462K |
| 2021 | 4,133 | $300K |
| 2022 | 2,517 | $282K |
| 2023 | 4,425 | $300K |
| 2024 | 3,848 | $228K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 24,461 | 2,060 | $2.48M |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 126 | 61 | $56K |
| A4657 | Syringe, with or without needle, each | 6,839 | 1,093 | $973.28 |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 10,397 | 886 | $203.53 |
| J1270 | Injection, doxercalciferol, 1 mcg | 6,576 | 564 | $78.58 |
| J1756 | Injection, iron sucrose, 1 mg | 2,395 | 623 | $17.46 |
| 84466 | 193 | 159 | $0.00 | |
| 90670 | 18 | 18 | $0.00 | |
| 83970 | 72 | 55 | $0.00 | |
| 85041 | 142 | 119 | $0.00 | |
| 82108 | 34 | 28 | $0.00 | |
| 85048 | 140 | 118 | $0.00 | |
| 83540 | 51 | 42 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 13 | 13 | $0.00 |
| 82728 | 51 | 42 | $0.00 | |
| G0009 | Administration of pneumococcal vaccine | 18 | 18 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 33 | 25 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 30 | 24 | $0.00 |
| 90674 | 13 | 13 | $0.00 |